Abstract
BackgroundPharmaco-epidemiological studies on TNF-inhibitors (TNF-I) in rheumatoid arthritis (RA) and spondyloarthritis (SpA) are providing useful data about effectiveness and safety in clinical practice.ObjectivesTo compare drug survival in RA and SpA...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have